MedTrace Logo

Supportive Treatment of Severe Heart Failure by Renal Denervation

NCT02638324 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-03-12

No results posted yet for this study

Summary

The overactivity of sympathetic nervous system is worsening the hemodynamic state of heart failure patients. The present study is planned to reduce the sympathetic tone in patients with severe heart failure by renal nervous denervation.

Conditions

Interventions

PROCEDURE

Renal nervous denervation

The heart failure patients will undergo renal nervous denervation if they have not properly responded to medication and biventricular pacing therapy.

Sponsors & Collaborators

  • Satakunta Central Hospital

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Mari-Anne Vaittinen, MD · Vaasa Central Hospitla

  • Mari-Anne Vaittinen, MD · Vaasa Central Hospital, Vaasa, Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2018-12-31
Completion
2019-01-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02638324 on ClinicalTrials.gov